Biomarin Pharmaceutical stockBMRN
Biomarin Pharmaceutical trades at $56.12, 20.9% below its 52-week high (Aug 12, 2026). The price is below its 50- and 200-day averages, a downtrend. −5.6% year to date, +6.3% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 24, 2027.
Ratings, candles, signals and the screener for BMRN — after you log in
Open the terminalFrequently asked questions about Biomarin Pharmaceutical
What is the Biomarin Pharmaceutical stock price?
At the close on Nov 5, 2026: $56.12 (−1.77% on the day). 52-week high: $70.98 on Aug 12, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Biomarin Pharmaceutical report earnings?
The next quarterly report is on Feb 24, 2027. Last quarter, earnings per share changed +244% year over year, revenue +32%.
Does Biomarin Pharmaceutical pay dividends?
No, Biomarin Pharmaceutical does not pay dividends.
Where does Biomarin Pharmaceutical trade and how to buy it?
Ticker BMRN, exchange Nasdaq, listed since 1999. You can buy it through a broker with access to US exchanges.
Should I buy Biomarin Pharmaceutical now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for BMRN are in the terminal after you log in.